Medicine guide
Orlaam
·
- Prescription status not stated
- Pain, sleep, mood, epilepsy and the brain
- Active substance
- Levacetylmethadol
- Made by
- Sipaco Internacional Lda.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- ORLAAM is indicated for the substitution maintenance treatment of opiate addiction in adults previously treated with methadone, as part of a comprehensive treatment plan including medical, social and psychological care. ORLAAM should be administered under the supervision of physicians with experience in addiction treatment and whenever practicable, in centres specialising in the treatment of drug addiction. ORLAAM is not intended for take home use.
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | Sipaco Internacional Lda. |
|---|---|
| Active substance | Levacetylmethadol |
| Used in | Pain, sleep, mood, epilepsy and the brain |
| Classification | N02AC · Pain, sleep, mood, epilepsy and the brain |
| Authorised on | 1997-07-01 |
| Last updated by the regulator | 2002-06-30 |
| EMA product number | EMEA/H/C/000077 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).